Selective inhibition of glycosyltransferases by bivalent imidazolium salts
- 1 March 2013
- journal article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry
- Vol. 21 (5), 1305-1311
- https://doi.org/10.1016/j.bmc.2012.12.034
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Inhibition of Galactosyltransferases by a Novel Class of Donor AnaloguesJournal of Medicinal Chemistry, 2012
- The anti-malarial activity of bivalent imidazolium saltsBioorganic & Medicinal Chemistry, 2011
- Levels of specific serum N-glycans identify breast cancer patients with higher circulating tumor cell countsAnnals of Oncology, 2010
- CSLEX (Sialyl Lewis X) is a Useful Tumor Marker for Monitoring of Breast Cancer PatientsJapanese Journal of Clinical Oncology, 2010
- Anti-Plasmodium activity of imidazolium and triazolium saltsBioorganic & Medicinal Chemistry, 2010
- Enhanced expression of 3-galactosyltransferase 5 activity is sufficient to induce in vivo synthesis of extended type 1 chains on lactosylceramides of selected human colonic carcinoma cell linesGlycobiology, 2008
- Glycosylation in bladder cancerInternational Journal of Clinical Oncology, 2008
- The Role of Galactosyltransferases in Cell Surface Functions and in the Immune SystemDrug News & Perspectives, 2006
- Cloning, Expression, and Characterization of a Novel UDP-galactose:β-N-Acetylglucosamine β1,3-Galactosyltransferase (β3Gal-T5) Responsible for Synthesis of Type 1 Chain in Colorectal and Pancreatic Epithelia and Tumor Cells Derived TherefromOnline Journal of Public Health Informatics, 1999
- Synthesis of a new inhibitor of the UDP-GalNAc: Polypeptide galactosaminyl transferaseBiochemical and Biophysical Research Communications, 1991